Skip to main content

Forest Plots of Adverse Effects

  • Chapter
  • First Online:
Analysis of Safety Data of Drug Trials

Abstract

For the analysis of efficacy data in clinical drug trials, generally, continuous data are applied. For the analysis of safety data, in contrast, usually proportions of patients with adverse effects are assessed.

The prevalences of adverse effects can be estimated with odds values of patients with adverse effects. The chance of adverse effects of a treatment versus that of a control can be approximated from the ratios of their odds values.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cleophas, T.J., Zwinderman, A.H. (2019). Forest Plots of Adverse Effects. In: Analysis of Safety Data of Drug Trials. Springer, Cham. https://doi.org/10.1007/978-3-030-05804-3_5

Download citation

Publish with us

Policies and ethics